AMENDMENT TO LICENSE AGREEMENT DIALYSATE TRIFERIC®License Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus
This AMENDMENT TO LICENSE AGREEMENT (the “AMENDMENT”) is executed as of October 7, 2018 (“EFFECTIVE DATE”) by and between Charak, LLC, whose legal address is 2505 Seascape Drive, Las Vegas, Nevada 89128, Dr. Ajay Gupta, an individual, having a principle residence at 2505 Seascape Drive, Las Vegas, Nevada 89128 (hereafter “DR. GUPTA”) (DR. GUPTA and Charak, LLC are collectively herein “CHARAK”), and Rockwell Medical, Inc., having a principal place of business at 30142 Wixom Road, Wixom, Michigan 48393 (“RM” or “ROCKWELL”). CHARAK and ROCKWELL are each a “PARTY” and collectively the “PARTIES.”
FIRST AMENDMENT TO FIRST AMENDED AND RESTATED PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus
This First Amendment to First Amended and Restated Products Purchase Agreement (the “First Amendment”) is entered into as of the 1st day of January, 2019 (“First Amendment Effective Date”) by and between DaVita Inc. (fka DaVita Healthcare Partners Inc.), a Delaware corporation having a principal place of business at 2000 16th Street, Denver, Colorado 80202 (“DaVita”) and Rockwell Medical, Inc., a Michigan corporation with a principal place of business at 30142 Wixom Road, Wixom, Michigan 48383 (“Rockwell”) (each a “Party” and collectively, the “Parties”).
SECOND AMENDMENT TO FIRST AMENDED AND RESTATED PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus
This Second Amendment to First Amended and Restated Products Purchase Agreement (the “Second Amendment”) is entered into as of the 1st day of February, 2019 (“Second Amendment Effective Date”) by and between DaVita Inc. (fka DaVita Healthcare Partners Inc.), a Delaware corporation having a principal place of business at 2000 16th Street, Denver, Colorado 80202 (“DaVita”) and Rockwell Medical, Inc., a Michigan corporation with a principal place of business at 30142 Wixom Road, Wixom, Michigan 48383 (“Rockwell”) (each a “Party” and collectively, the “Parties”).
STOCK OPTION AGREEMENTStock Option Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • Michigan
THIS STOCK OPTION AGREEMENT, dated as of the grant date set forth above (the “Grant Date”), is made by and between Rockwell Medical, Inc., a Michigan corporation (the “Company”), and the individual set forth above, who is an employee of the Company (the “Optionee”). Any capitalized terms used herein but not otherwise defined shall have the meaning set forth in the Company’s 2018 Long Term Incentive Plan (the “Plan”).
MASTER SERVICES AND IP AGREEMENTMaster Services and Ip Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Master Services and IP Agreement (the “Agreement”) is effective October 7, 2018 (“Effective Date”) by and between Charak, LLC, whose legal address is 2505 Seascape Drive, Las Vegas, NV 89128, Dr. Ajay Gupta, an individual, having a principle residence at 2505 Seascape Drive, Las Vegas, Nevada 89128 (hereafter “Dr. Gupta”) (Dr. Gupta and Charak, LLC are collectively herein “Charak”), and Rockwell Medical, Inc., having a principal place of business at 30142 Wixom Road, Wixom, Michigan 48393 (“Rockwell”). Charak and Rockwell are each a “Party” and collectively the “Parties.” The Parties agree as follows:
COMMERCIALIZATION AND TECHNOLOGY LICENSE AGREEMENTCommercialization and Technology License Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This COMMERCIALIZATION AND TECHNOLOGY LICENSE AGREEMENT (the “AGREEMENT”) is executed as of October 7, 2018 (“EFFECTIVE DATE”) by and between Charak, LLC, whose legal address is 2505 Seascape Drive, Las Vegas, Nevada 89128, Dr. Ajay Gupta, an individual, having a principle residence at 2505 Seascape Drive, Las Vegas, Nevada 89128 (hereafter “DR. GUPTA”) (DR. GUPTA and Charak, LLC are collectively herein “CHARAK”), and Rockwell Medical, Inc., having a principal place of business at 30142 Wixom Road, Wixom, Michigan 48393 (“RM” or “ROCKWELL”). CHARAK and ROCKWELL are each a “PARTY” and collectively the “PARTIES.” The PARTIES hereby agree as follows:
TECHNOLOGY LICENSE AGREEMENT TPN TRIFERIC®Technology License Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This COMMERCIALIZATION AND TECHNOLOGY LICENSE AGREEMENT (the “AGREEMENT”) is executed as of October 7, 2018 (“EFFECTIVE DATE”) by and between Charak, LLC, whose legal address is 2505 Seascape Drive, Las Vegas, Nevada 89128, Dr. Ajay Gupta, an individual, having a principle residence at 2505 Seascape Drive, Las Vegas, Nevada 89128 (hereafter “DR. GUPTA”) (DR. GUPTA and Charak, LLC are collectively herein “CHARAK”), and Rockwell Medical, Inc., having a principal place of business at 30142 Wixom Road, Wixom, Michigan 48393 (“RM” or “ROCKWELL”). CHARAK and ROCKWELL are each a “PARTY” and collectively the “PARTIES.” The PARTIES hereby agree as follows:
